The Anti-Diabetic Drug Metformin from the Neuropathy Perspective
- PMID: 33389958
- PMCID: PMC7801752
- DOI: 10.4093/dmj.2020.0252
The Anti-Diabetic Drug Metformin from the Neuropathy Perspective
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Comment on
-
Metformin Preserves Peripheral Nerve Damage with Comparable Effects to Alpha Lipoic Acid in Streptozotocin/High-Fat Diet Induced Diabetic Rats.Diabetes Metab J. 2020 Dec;44(6):842-853. doi: 10.4093/dmj.2019.0190. Epub 2020 May 28. Diabetes Metab J. 2020. PMID: 32602278 Free PMC article.
References
-
- Won J, Kwon H, Kim C, Lee J, Park T, Ko K, Cha B. Prevalence and clinical characteristics of diabetic peripheral neuropathy in hospital patients with type 2 diabetes in Korea. Diabetic Med. 2012;29:e290–6. - PubMed
-
- American Diabetes Association. 11. Microvascular complications and foot care: standards of medical care in diabetes-2020. Diabetes Care. 2020;43(Suppl 1):S135–51. - PubMed
-
- Cryer PE. Comment on: Nathan DM, Buse JB, Davidson MB et al (2006) Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 49:1711–1721. Diabetologia. 2007;50:222–4. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
